Biomarkers in Barrett Esophagus
Authors:
- Kausilia Krishnawatie KrishnadathKKKausilia Krishnawatie Krishnadath
- Brian J. ReidBRBrian J. Reid
- Kenneth K. WangKWKenneth K. Wang
- 1 April 2001
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 76 (4) , 438-446
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancerOncogene, 1999
- PCNA binding proteinsFrontiers in Bioscience-Landmark, 1999
- Low Glutathione and Glutathione S‐Transferase Levels in Barrett's Esophagus as Compared to Normal Esophageal EpitheliumJapanese Journal of Cancer Research, 1999
- Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight casesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequenceSurgical Oncology, 1995
- Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variablesInternational Journal of Cancer, 1995
- Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus.Gut, 1989
- Cancer genes in manCurrent Problems in Cancer, 1983